"It has been a pleasure to work with the experienced drug development team at Paracelsus, Inc. who have..."

Selexagen Therapeutics, Inc.
Patrick M. O'Connor, Ph.D., CSO

Veterinary Pathology

Study pathologist services for non-GLP and GLP studies including carcinogenicity studies
Peer review pathologist for non-GLP, GLP studies and carcinogenicity studies at the CRO
Safety and risk assessment of novel compounds
Expertise in investigative strategies to study mechanism of disease and toxicity
Interpretation of investigative procedures including immunohistochemistry, electron microscopy and target tissue cross reactivity
Project subject matter expertise
Nonclinical study design and protocol development
Review and interpretation of nonclinical data
Review and integration of scientific literature
Preparation of nonclinical summary regulatory documents
Monitoring CRO studies to ensure compliance to study protocol and standard operating procedures

Services